πŸ‡ΊπŸ‡Έ FDA
Patent

US 7973057

Thalidomide analogs

granted A61PA61P25/00A61P35/00

Quick answer

US patent 7973057 (Thalidomide analogs) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P25/00, A61P35/00, A61P35/04, A61P37/06